Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q3 2019 Atara Biotherapeutics Inc Earnings Call Transcript

Nov 07, 2019 / 01:00PM GMT
Release Date Price: $338 (+11.18%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Atara Biotherapeutics Q3 2019 Financial Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I'd now like to hand the conference over to your speaker today, Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics. Please go ahead, sir.

John Craighead
Atara Biotherapeutics, Inc. - VP of IR & Corporate Communications

Thank you, operator. Good morning, everyone, and welcome to Atara's Third Quarter 2019 Conference Call. On today's call, we plan to discuss our third quarter financial results, as well as recent clinical, operational and strategic progress. Earlier this morning, we issued a press release providing an overview of the company's third quarter 2019. This press release as well as an updated investor presentation are available in the Investor & Media section at atarabio.com.

I'm joined on today's call by Dr. Pascal Touchon, President and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot